Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Judges For BioScapes Competition Announced

By Drug Discovery Trends Editor | September 22, 2009

The judges for the sixth annual BioScapes International Digital Imaging Competition have been announced by Olympus. This year’s distinguished judges will gather in October to appraise more than a thousand life science images and movies submitted from around the world, honoring the most exceptional and significant with prizes and worldwide publicity. The 2009 BioScapes Competition closes for entries on September 30.

This year’s judging panel includes four individuals renowned for their knowledge of microscope-based imaging.  They are Thomas Deerinck, National Center for Microscopy and Imaging Research, University of California, San Diego; Kenneth N. Fish, Ph.D., University of Pittsburgh; Douglas Murphy, Ph.D., Howard Hughes Medical Institute, Janelia Farms Research Campus, Virginia; and Julie Theriot, Ph.D., Stanford University School of Medicine in California. 

The Olympus BioScapes International Digital Imaging Competition, widely recognized as the world’s leading international life science light microscopy photo forum, pays tribute to the amazing stories being told through the images and movies captured in today’s laboratories, and on the remarkable confluence of science and art.  The Competition carries a top prize valued at $5,000. Nine other submissions win prizes, and honorable mentions also are awarded.  Each entrant can submit up to five still images, image sequences, or movies. Any magnification and brand of compound light microscope can be used; judges are given no equipment/brand information when judging. Winners will be notified in October, and publicly announced in November.

Date: September 15, 2009
Source: Olympus 


Filed Under: Drug Discovery

 

Related Articles Read More >

NIH is reorganizing clinical trial funding by trial type instead of disease
Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE